Document is current
Any future updates will be listed below
-
Authors
Abdolahi, Mina
Karimi, Elmira
Sarraf, Payam
Tafakhori, Abbas
Siri, Goli
Salehinia, Farahnaz
Sedighiyan, Mohsen
Asanjarani, Behzad
Badeli, Mostafa
Abdollahi, Hamed
Yoosefi, Niyoosha
yousefi, Abolghasem
rad, Amir Shayegan
Djalali, Mahmoud
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02532023 at ClinicalTrials.govDocuments that mention this clinical trial
The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial
https://doi.org/10.1186/s13104-021-05700-x
- License Information
-
More Information
Article History
Received: 11 March 2021
Accepted: 14 July 2021
First Online: 23 July 2021
Declarations
:
: Present investigation was approved by the Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran (with ID number: IR.TUMS.REC.1394.462) and registered in the ClinicalTrials.gov (ID: NCT02532023). The Participants completed a written consent prior of including into the study and being informed about study protocol.
: Not Applicable.
: The authors in this study declare no conflict of interest.
